cbb, I think both us and Ammarin management have to admit and reflect on - why yesterdays 3. Q presentation ended as a disaster in the market.
----------------------
Lest just for a minute leave the damaging Class Act out - though that surely 'have affected negatively' the trust in AMRN for the last 2 weeks.
-----------------------
Actually KM did everything right in the presentation. He talked loud and clear and to the point' of where Amarin are in USA and Europe.
He clearly knows details, and sounds in every way engaged and optimistic answering questions in the end of presentation - so what is the problem - why the negative/red reaction in the market ?
------------------------
Lack of 'real news' - like eg. "We are negotiating a general partner deal - possible full BO". Probably the only announcement from KM yesterday - that could have turned the tide to positive - SP going North for real.
------------------------
It does hurt everyone involved with Amarin to se that generics are 'eating away at our lunch 'for free' every week - everything based on fraud.
Of course 'roll out' in Europe and elsewhere will take time - but patience among investors are running thin - looking at the 'ever locked' SP - $ 4- 5 since Nevada ruling - only exception the short Covid blip.
------------------------
Digging a little deeper in possible KM strategy - you can interpret what he is doing - 'as preparing' a Big Pharma - BO.
The way he underlines the complete line of 'applying for approval' in many countries WW - 22 - 23 - 24 could be seen at doing the time-consuming groundwork say Pfizer or Merck to roll out the big sales-canons.
News 
Market Data 
Discover 
